Duke Lupus Registry
Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women. The Duke Lupus Registry will collect information and blood samples from patients with lupus (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The goal of this Registry is to understand how lupus changes over time so that we can improve the treatment of patients with lupus.
Conditions:
🦠 Systemic Lupus Erythematosus 🦠 Cutaneous Lupus
🗓️ Study Start (Actual) July 2007
🗓️ Primary Completion (Estimated) June 2027
✅ Study Completion (Estimated) June 2027
👥 Enrollment (Estimated) 1000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Durham, North Carolina, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus
    • * Patient of a rheumatologist at Duke University Medical Center

    Exclusion Criteria:

    • * Inability to travel to Duke for follow-up visits
    • * Inability to speak English
    • * Not able to provide informed consent
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 6 August 2007
  • First Submitted that Met QC Criteria 6 August 2007
  • First Posted 8 August 2007

Study Record Updates

  • Last Update Submitted that Met QC Criteria 7 December 2023
  • Last Update Posted 13 December 2023
  • Last Verified December 2023